While 1 in 3 Americans (or 100 million people) have liver disease, many are unaware until the disease has progressed to later stages at which point the disease is no longer curable, patient outcomes are poor and healthcare spending can cost up to $1,000,000 per patient.

The sole diagnostic tool is a liver biopsy, which is expensive, invasive, prone to sampling error, and bleeding. Imaging tools fail in nearly 60% of patients and there are zero accurate noninvasive tools. Liver disease is intervening with a healthy aging society.

Embryonic Stem Cells